Vericel Corp (VCEL):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Vericel Corp (VCEL) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7216
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Vericel Corp (Vericel) develops and markets advanced cell therapies for sports medicine and severe burn domains. Its major products include MACI (autologous cultured chondrocytes on porcine collagen membrane) for the treatment of cartilage defects; and Epicel cultured epidermal autografts for skin replacement. The company is also developing ixmyelocel-T technology, a patient-specific multicellular therapy for the treatment of advanced heart failure due to ischemic dilated cardiomyopathy (DCM). It has manufacturing facilities in Cambridge, Massachusetts; Ann Harbour, Michigan and Kastrup, Denmark. The company sells its products through cell therapy specialists. Vericel is headquartered in Cambridge, the US.

Vericel Corp (VCEL) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Vericel Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Vericel Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Vericel Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Vericel Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Vericel Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Vericel Corp, Medical Equipment, Deal Details 10
Innovative Cellular Therapeutics Enters into Licensing Agreement with Vericel 10
Equity Offering 11
Vericel Plans to Raise up to USD200 Million in Public Offering of Securities 11
Vericel Raises USD74.8 Million in Public Offering of Shares 12
Vericel Raises USD19.6 Million in Public Offering of Shares 14
Aastrom Biosciences Raises USD15 Million in Private Placement of Shares 15
Aastrom Biosciences Raises USD40 Million in Public Offering of Shares 16
Aastrom Biosciences Completes Public Offering Of Shares For US$9 Million 18
Vericel Corp – Key Competitors 19
Vericel Corp – Key Employees 20
Vericel Corp – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Financial Announcements 22
Aug 06, 2018: Vericel Reports Record Second Quarter Revenues of $19.0 Million and Raises Full Year 2018 Revenue Guidance 22
May 08, 2018: Vericel Reports First Quarter 2018 Financial Results 24
Mar 05, 2018: Vericel Reports Fourth Quarter and Year End 2017 Financial Results and Provides Full Year 2018 Financial Guidance 26
Nov 07, 2017: Vericel Reports Third-Quarter 2017 Financial Results 28
Aug 09, 2017: Vericel Reports Second-Quarter 2017 Financial Results 29
May 10, 2017: Vericel Reports First-Quarter 2017 Financial Results 31
Mar 10, 2017: Vericel Reports Fourth-Quarter and Year-End 2016 Financial Results 33
Corporate Communications 35
Aug 20, 2018: Vericel names Jonathan Hopper as chief medical officer 35
Apr 10, 2017: Vericel Announces Appointment of Michael Halpin as Senior Vice President, Quality and Regulatory Affairs 36
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Tables
Vericel Corp, Medical Equipment, Key Facts, 2017 2
Vericel Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Vericel Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Vericel Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Vericel Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Vericel Corp, Deals By Market, 2012 to YTD 2018 8
Vericel Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Innovative Cellular Therapeutics Enters into Licensing Agreement with Vericel 10
Vericel Plans to Raise up to USD200 Million in Public Offering of Securities 11
Vericel Raises USD74.8 Million in Public Offering of Shares 12
Vericel Raises USD19.6 Million in Public Offering of Shares 14
Aastrom Biosciences Raises USD15 Million in Private Placement of Shares 15
Aastrom Biosciences Raises USD40 Million in Public Offering of Shares 16
Aastrom Biosciences Completes Public Offering Of Shares For US$9 Million 18
Vericel Corp, Key Competitors 19
Vericel Corp, Key Employees 20
Vericel Corp, Other Locations 21
Vericel Corp, Subsidiaries 21

List of Figures
Vericel Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Vericel Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Vericel Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Vericel Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Vericel Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Vericel Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Vericel Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Vericel Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Vericel Corp (VCEL):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Orient Europharma Co Ltd (4120):企業の財務・戦略的SWOT分析
    Summary Orient Europharma Co Ltd (OEP) is a pharmaceutical company that manufactures and markets prescription medication, Innovative medical and Infant health products. The company’s prescription medication products include cardiovascular medication, immunology medicine, metabolism medicine, neurolo …
  • Intuitive Surgical Inc (ISRG)-医療機器分野:企業M&A・提携分析
    Summary Intuitive Surgical Inc (Intuitive Surgical) is a provider of robotic-assisted minimally invasive surgery (MIS) devices. Its portfolio encompasses da Vinci Surgical Systems, InSite and Firefly Fluorescence imaging systems (Firefly), instruments and accessories and training technologies. The c …
  • Attunity Ltd (ATTU):企業の財務・戦略的SWOT分析
    Summary Attunity Ltd (Attunity) is a technology company that provides data management software, cloud database replication solutions, and google cloud database tools. The company provides data management software solutions that enable access, sharing, management, and distribution of data. It offers …
  • Daimler AG:企業のM&A・事業提携・投資動向
    Daimler AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Daimler AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • OGK-2 (OGKB):企業の財務・戦略的SWOT分析
    OGK-2 (OGKB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • Red Lion Hotels Corporation:企業の戦略・SWOT・財務情報
    Red Lion Hotels Corporation - Strategy, SWOT and Corporate Finance Report Summary Red Lion Hotels Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Pact Group Holdings Ltd:企業の戦略・SWOT・財務情報
    Pact Group Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Pact Group Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Perenco Holdings:企業の戦略的SWOT分析
    Perenco Holdings - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Innovation Pharmaceuticals Inc (IPIX):医療機器:M&Aディール及び事業提携情報
    Summary Innovation Pharmaceuticals Inc (Innovation Pharmaceuticals), formerly Cellceutix Corp, is a biopharmaceutical company that discovers and advances medical therapies with dermatology, oncology, anti-inflammatory and antibiotic applications. The company provides pipeline products such as kevetr …
  • Santee Cooper:企業の戦略的SWOT分析
    Santee Cooper - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Chembio Diagnostic, Inc. (CEMI)-医療機器分野:企業M&A・提携分析
    Summary Chembio Diagnostic, Inc. (Chembio) develops, manufactures, markets and licenses point-of-care diagnostic (POCs) tests for the detection of infectious diseases. The company offers products to prevent the spread of infectious diseases with solutions like Dual Path Platform (DPP), which makes P …
  • Benesse Holdings, Inc. (9783):企業の財務・戦略的SWOT分析
    Benesse Holdings, Inc. (9783) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Solvay SA (SOLB):電力:M&Aディール及び事業提携情報
    Summary Solvay SA (Solvay) is a chemical manufacturing company, which carries out production of specialty polymers, essential chemicals, silica and rare earth systems, consumer chemicals, polyamide and intermediates. In addition, the company manufactures additives, engineering plastics, diphenols an …
  • XsunX Inc (XSNX):企業の財務・戦略的SWOT分析
    XsunX Inc (XSNX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Fukuda Denshi Co Ltd (6960):医療機器:M&Aディール及び事業提携情報
    Summary Fukuda Denshi Co Ltd (Fukuda Denshi) is a medical device company, which develops, manufactures, and commercializes medical equipment including cardiology, patient monitoring, vascular screening and ultrasound systems. The company’s product portfolio includes electrocardiographs, stress tests …
  • Esprinet S.p.A. (PRT):企業の財務・戦略的SWOT分析
    Esprinet S.p.A. (PRT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Volkswind GmbH:電力:M&Aディール及び事業提携情報
    Summary Volkswind GmbH (Volkswind) a subsidiary of Axpo Holding AG, is an independent renewable power producer. It undertakes the planning, development, construction and operations of wind power plants. Volkswind builds wind farms with wind turbines from various suppliers including Seimens, Enercon, …
  • Seagate Technology Public Limited Company:企業の戦略・SWOT・財務情報
    Seagate Technology Public Limited Company - Strategy, SWOT and Corporate Finance Report Summary Seagate Technology Public Limited Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Carmanah Technologies Corporation (CMH):電力:M&Aディール及び事業提携情報
    Summary Carmanah Technologies Corporation (Carmanah Technologies) is a provider of signal and solar-based light emitting diode (LED) solutions for infrastructure. The company designs, develops and distributes solar powered LED lighting, and solar powered systems and equipment. It also designs, devel …
  • Poslovni sistem Mercator, d.d.:戦略・SWOT・企業財務分析
    Poslovni sistem Mercator, d.d. - Strategy, SWOT and Corporate Finance Report Summary Poslovni sistem Mercator, d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆